JAK2 and neoplasm: BMAs secrete a large amount of IL-6 [160], which induces EMT in cancer cells through the JAK2/STAT3 pathway [161] and increases the metastatic potential of tumor cells by promoting tumor cell survival through the PI3K/AKT pathway [162].